K2 + D3 — the pair that should always travel together

Vitamin D3 tells the body to absorb more calcium from food. Vitamin K2 tells the body where to put it. Without K2, D3 increases calcium absorption — but the calcium has no chaperone. It deposits in places it shouldn't, including the walls of arteries.

This is, structurally, the entire reason any responsible heart-aware supplement pairs them. If you're taking D3 alone, you're potentially making the very thing you're trying to prevent worse. If you're taking K2 + D3 together, you're routing the calcium to bone, where it belongs, and away from soft tissue, where it doesn't.

K2 has two forms — and they are not equivalent

Look at the label. There are two forms of K2 commercially available:

• MK-4 — short half-life (~1 hour). Cheap. The form most low-cost supplements use because, on the bottle, "K2 (MK-4)" is indistinguishable from "K2 (MK-7)." It is, in practice, very different.
• MK-7 — long half-life (~72 hours). Expensive. The form used in the Rotterdam Heart Study and the bone-density trials that built the entire K2 + D3 case.

If you take MK-4 once a day, your blood level of K2 spikes for about an hour, then falls back to baseline. You're not getting continuous coverage. To replicate the effect of MK-7 with MK-4, you'd need to dose roughly every 6 hours throughout the day. Almost no one does this.

The cleverness of the cheaper version

A bottle that says "K2 + D3" can be filled with MK-4 at 100mcg. The label is technically accurate. The cost-per-bottle is a fraction of the MK-7 version. The shopper who knows enough to look for K2 + D3 — but not enough to ask which form — has been served exactly what looks like the right thing.

This is one of the cleanest examples in the supplement category of how a label can be both technically true and functionally a lie.

The dosage that matches the studies

The cardiovascular benefit shown in the Rotterdam trial — a 50% reduction in arterial calcification, a 50% reduction in cardiovascular mortality — was achieved at roughly 90–200mcg/day of MK-7. The bone density studies used similar doses, with D3 at 1,000–2,000 IU.

Most "K2 + D3" supplements use 25–45mcg of MK-7 (sub-clinical) or 100mcg of MK-4 (functionally meaningless), paired with 1,000 IU of D3 (correct).

The math, again, is unforgiving. If the dose is well below the studied range, the effect is not a "smaller version of the benefit." The effect, in many cases, is "no measurable benefit at all."

How to know what you actually have

Three things to check on any K2 + D3 supplement:

1. Does it specify MK-7? (If it says only "K2," assume MK-4 unless told otherwise.)
2. Is the MK-7 dose at the lower bound of the Rotterdam trial range — 90mcg or higher?
3. Is the D3 paired at 1,000–2,000 IU?

If all three are yes, you have what the studies were testing. If any are no, you have a supplement that costs the same as one that works, but isn't the same.

— Pepperton uses 90mcg MK-7 and 2,000 IU D3 per dose — calibrated to the lower bound of the Rotterdam trial range, on the same label, no proprietary blend math.